• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素K依赖蛋白、华法林与血管钙化

Vitamin K-dependent proteins, warfarin, and vascular calcification.

作者信息

Danziger John

机构信息

Renal Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Clin J Am Soc Nephrol. 2008 Sep;3(5):1504-10. doi: 10.2215/CJN.00770208. Epub 2008 May 21.

DOI:10.2215/CJN.00770208
PMID:18495950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4571144/
Abstract

Vitamin K-dependent proteins (VKDPs) require carboxylation to become biologically active. Although the coagulant factors are the most well-known VKDPs, there are many others with important physiologic roles. Matrix Gla Protein (MGP) and Growth Arrest Specific Gene 6 (Gas-6) are two particularly important VKDPs, and their roles in vascular biology are just beginning to be understood. Both function to protect the vasculature; MGP prevents vascular calcification and Gas-6 affects vascular smooth muscle cell apoptosis and movement. Unlike the coagulant factors, which undergo hepatic carboxylation, MGP and Gas-6 are carboxylated within the vasculature. This peripheral carboxylation process is distinct from hepatic carboxylation, yet both are inhibited by warfarin administration. Warfarin prevents the activation of MGP and Gas-6, and in animals, induces vascular calcification. The relationship of warfarin to vascular calcification in humans is not fully known, yet observational data suggest an association. Given the high risk of vascular calcification in those patients with chronic kidney disease, the importance of understanding warfarin's effect on VKDPs is paramount. Furthermore, recognizing the importance of VKDPs in vascular biology will stimulate new areas of research and offer potential therapeutic interventions.

摘要

维生素K依赖性蛋白(VKDPs)需要羧化才能具有生物活性。尽管凝血因子是最广为人知的VKDPs,但还有许多其他具有重要生理作用的蛋白。基质Gla蛋白(MGP)和生长停滞特异性基因6(Gas-6)是两种特别重要的VKDPs,它们在血管生物学中的作用才刚刚开始被了解。二者都起到保护血管的作用;MGP可防止血管钙化,Gas-6则影响血管平滑肌细胞的凋亡和运动。与在肝脏进行羧化的凝血因子不同,MGP和Gas-6在血管内进行羧化。这种外周羧化过程不同于肝脏羧化,但二者都会被华法林抑制。华法林会阻止MGP和Gas-6的激活,在动物中会诱发血管钙化。华法林与人类血管钙化之间的关系尚不完全清楚,但观察数据表明存在关联。鉴于慢性肾病患者血管钙化的风险很高,了解华法林对VKDPs的影响至关重要。此外,认识到VKDPs在血管生物学中的重要性将激发新的研究领域并提供潜在的治疗干预措施。

相似文献

1
Vitamin K-dependent proteins, warfarin, and vascular calcification.维生素K依赖蛋白、华法林与血管钙化
Clin J Am Soc Nephrol. 2008 Sep;3(5):1504-10. doi: 10.2215/CJN.00770208. Epub 2008 May 21.
2
Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification.翻译后修饰调节基质γ-羧基谷氨酸蛋白的功能:对抑制血管平滑肌细胞钙化的重要性。
J Thromb Haemost. 2007 Dec;5(12):2503-11. doi: 10.1111/j.1538-7836.2007.02758.x. Epub 2007 Sep 10.
3
Involvement of Vitamin K-Dependent Proteins in Vascular Calcification.维生素 K 依赖性蛋白在血管钙化中的作用。
J Cardiovasc Pharmacol Ther. 2019 Jul;24(4):323-333. doi: 10.1177/1074248419838501. Epub 2019 Mar 24.
4
Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?维生素 K 治疗终末期肾病患者的心血管疾病:是否有希望?
Curr Vasc Pharmacol. 2021;19(1):77-90. doi: 10.2174/1570161118666200320111745.
5
[Vitamin K, bone metabolism and vascular calcification in chronic kidney disease].[慢性肾脏病中的维生素K、骨代谢与血管钙化]
Przegl Lek. 2011;68(9):629-32.
6
Warfarin and Vascular Calcification.华法林与血管钙化
Am J Med. 2016 Jun;129(6):635.e1-4. doi: 10.1016/j.amjmed.2015.11.032. Epub 2015 Dec 20.
7
Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves.华法林会导致大鼠动脉和心脏瓣膜的弹性层迅速钙化。
Arterioscler Thromb Vasc Biol. 1998 Sep;18(9):1400-7. doi: 10.1161/01.atv.18.9.1400.
8
Therapeutic warfarin use and the extrahepatic functions of vitamin K-dependent proteins.华法林的治疗应用与维生素K依赖蛋白的肝外功能
Br J Biomed Sci. 2017 Oct;74(4):163-169. doi: 10.1080/09674845.2017.1336854. Epub 2017 Jun 28.
9
Prothrombin Loading of Vascular Smooth Muscle Cell-Derived Exosomes Regulates Coagulation and Calcification.血管平滑肌细胞衍生外泌体的凝血酶原负载调节凝血和钙化。
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):e22-e32. doi: 10.1161/ATVBAHA.116.308886. Epub 2017 Jan 19.
10
Warfarin-induced artery calcification is accelerated by growth and vitamin D.华法林诱导的动脉钙化会因生长和维生素D而加速。
Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):317-27. doi: 10.1161/01.atv.20.2.317.

引用本文的文献

1
Calcium binding by γ-carboxyglutamic acid: it takes two to tether.γ-羧基谷氨酸与钙的结合:需要两者相互 tether(此处“tether”可能是一个特定术语,在医学领域可能有特定含义,暂按原文翻译)才能结合。
Res Pract Thromb Haemost. 2025 Jun 27;9(5):102964. doi: 10.1016/j.rpth.2025.102964. eCollection 2025 Jul.
2
Calciphylaxis in End-Stage Renal Disease: A Case of Nonhealing Ulcer and Diagnostic Challenges.终末期肾病中的钙化防御:一例难愈性溃疡及诊断挑战
Cureus. 2025 May 17;17(5):e84300. doi: 10.7759/cureus.84300. eCollection 2025 May.
3
In vitro evaluation of global coagulation potential of emicizumab and warfarin using rotational thromboelastometry.使用旋转血栓弹力图对艾美赛珠单抗和华法林的整体凝血潜力进行体外评估。
Int J Hematol. 2025 Apr 28. doi: 10.1007/s12185-025-03986-2.
4
Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention.维生素K在中风和阿尔茨海默病中的特性:保护与预防中的双面神雅努斯
Molecules. 2025 Feb 24;30(5):1027. doi: 10.3390/molecules30051027.
5
Mechanisms of Cardiovascular Calcification and Experimental Models: Impact of Vitamin K Antagonists.心血管钙化的机制及实验模型:维生素K拮抗剂的影响
J Clin Med. 2024 Feb 29;13(5):1405. doi: 10.3390/jcm13051405.
6
Cytochrome P450 Family and Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation Activity.细胞色素P450家族、单倍型图谱绘制及其与肝脏基因表达和维生素K羟化活性的关联
ACS Pharmacol Transl Sci. 2024 Feb 3;7(3):716-732. doi: 10.1021/acsptsci.3c00287. eCollection 2024 Mar 8.
7
Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症患者抗凝处方的药物基因组学考量
J Clin Med. 2023 Dec 15;12(24):7710. doi: 10.3390/jcm12247710.
8
Vitamin K and Calcium Chelation in Vascular Health.维生素K与血管健康中的钙螯合作用
Biomedicines. 2023 Nov 27;11(12):3154. doi: 10.3390/biomedicines11123154.
9
Vitamin A, D, E, and K as Matrix Metalloproteinase-2/9 Regulators That Affect Expression and Enzymatic Activity.维生素 A、D、E 和 K 作为基质金属蛋白酶-2/9 的调节剂,影响其表达和酶活性。
Int J Mol Sci. 2023 Dec 1;24(23):17038. doi: 10.3390/ijms242317038.
10
Zebrafish Models to Study Ectopic Calcification and Calcium-Associated Pathologies.斑马鱼模型在异位钙化及钙相关病变研究中的应用
Int J Mol Sci. 2023 Feb 8;24(4):3366. doi: 10.3390/ijms24043366.

本文引用的文献

1
Mechanisms of vascular calcification in chronic kidney disease.慢性肾脏病中血管钙化的机制
J Am Soc Nephrol. 2008 Feb;19(2):213-6. doi: 10.1681/ASN.2007080854. Epub 2007 Dec 19.
2
Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice.叶绿醌(维生素K1)在小鼠体内转化为甲基萘醌-4(维生素K2):甲基萘醌-4在小鼠大脑中积累的两种可能途径。
J Biol Chem. 2008 Apr 25;283(17):11270-9. doi: 10.1074/jbc.M702971200. Epub 2007 Dec 14.
3
Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.骨骼健康与骨质疏松症:维生素K的作用及抗凝剂的潜在拮抗作用
Nutr Clin Pract. 2007 Oct;22(5):517-44. doi: 10.1177/0115426507022005517.
4
Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index.羧化不全的基质GLA蛋白水平在透析患者中降低,且与钙磷代谢参数及主动脉增强指数相关。
Blood Purif. 2007;25(5-6):395-401. doi: 10.1159/000108629. Epub 2007 Sep 20.
5
Warfarin and aortic valve calcification in hemodialysis patients.华法林与血液透析患者的主动脉瓣钙化
J Nephrol. 2007 Jul-Aug;20(4):417-22.
6
Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification.翻译后修饰调节基质γ-羧基谷氨酸蛋白的功能:对抑制血管平滑肌细胞钙化的重要性。
J Thromb Haemost. 2007 Dec;5(12):2503-11. doi: 10.1111/j.1538-7836.2007.02758.x. Epub 2007 Sep 10.
7
Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?血液透析患者的心房颤动:抗凝指南适用吗?
Nephrology (Carlton). 2007 Oct;12(5):441-7. doi: 10.1111/j.1440-1797.2007.00835.x.
8
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.口服抗凝和抗血小板治疗与外周动脉疾病
N Engl J Med. 2007 Jul 19;357(3):217-27. doi: 10.1056/NEJMoa065959.
9
The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol.
J Thromb Haemost. 2007 Aug;5(8):1701-6. doi: 10.1111/j.1538-7836.2007.02630.x. Epub 2007 May 21.
10
Subclinical vitamin K deficiency in hemodialysis patients.血液透析患者的亚临床维生素K缺乏症
Am J Kidney Dis. 2007 Mar;49(3):432-9. doi: 10.1053/j.ajkd.2006.11.041.